Peter Feinberg, Director at Immuneering Corp (IMRX), bought 6,667 shares at $6.75 ($45K) on 2022-03-15, disclosed to the SEC on 2022-03-16.
Open-market purchase of $45k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| IMRX | BUY | 2025-10-01 | $53K | — | Filing → |
| IMRX | BUY | 2025-09-30 | $36K | — | Filing → |
| IMRX | BUY | 2025-06-23 | $127K | — | Filing → |